Prelude Capital Management’s ImageneBio IMA Stock Holding History
Bought
Maintained
Sold
Other funds holding IMA
BCM
Prelude Capital Management's IMA Position: Q2 2026 in Review
Prelude Capital Management sold out of ImageneBio (IMA) in Q2 2026, closing a stake of 12,990 shares — an estimated $65K sold.
Prelude Capital Management first reported a position in IMA in Q3 2024 and held it in 3 quarters. The position peaked at $93.1K in Q4 2025. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.
- Prelude Capital Management reported no remaining ImageneBio position as of Q2 2026 after selling out during the quarter.
- Prelude Capital Management sold 12,990 ImageneBio shares in Q2 2026, an estimated $65K.
- Prelude Capital Management first reported a position in ImageneBio in Q3 2024 and held it in 3 quarters.
- Prelude Capital Management's ImageneBio position peaked at $93.1K in Q4 2025.
- 35 funds tracked by Wall St. Rank held ImageneBio as of Q2 2026.
Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.